Vyome Holdings, Inc. (HIND)
2.09
+0.06
(+2.96%)
USD |
NASDAQ |
Oct 09, 16:00
Vyome Holdings Profit Margin (Quarterly) : -2.67K% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.67K% |
| March 31, 2026 | -3.12K% |
| December 31, 2025 | -3.50K% |
| September 30, 2025 | -24.84K% |
| June 30, 2025 | -617.6% |
| March 31, 2025 | -148.0% |
| December 31, 2024 | -499.3% |
| September 30, 2024 | -648.3% |
| June 30, 2024 | -81.17% |
| March 31, 2024 | -112.8% |
| December 31, 2023 | -85.67% |
| September 30, 2023 | -164.0% |
| June 30, 2023 | -155.0% |
| March 31, 2023 | -116.4% |
| December 31, 2022 | -534.1% |
| September 30, 2022 | -435.5% |
| June 30, 2022 | -326.6% |
| March 31, 2022 | -332.6% |
| December 31, 2021 | -1.13K% |
| September 30, 2021 | -477.3% |
| Date | Value |
|---|---|
| June 30, 2021 | -110.6% |
| March 31, 2021 | -151.3% |
| December 31, 2020 | -266.2% |
| September 30, 2020 | -143.8% |
| June 30, 2020 | -211.8% |
| March 31, 2020 | -674.5% |
| December 31, 2019 | -624.3% |
| September 30, 2019 | -1.11K% |
| June 30, 2019 | -1.75K% |
| March 31, 2019 | -467.0% |
| December 31, 2018 | -430.1% |
| September 30, 2018 | -225.8% |
| June 30, 2018 | -357.0% |
| March 31, 2018 | -900.9% |
| December 31, 2017 | -274.1% |
| September 30, 2017 | -329.0% |
| June 30, 2017 | -393.8% |
| March 31, 2017 | -526.2% |
| December 31, 2016 | -970.9% |
| September 30, 2016 | -680.5% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Cardiac Biotech Solutions, Inc. | -341.3% |
| Anika Therapeutics, Inc. | 10.15% |
| Enovis Corp. | -0.18% |
| Edwards Lifesciences Corp. | 13.87% |
| Perspective Therapeutics, Inc. | -33.31K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -200.6% |
| Return on Assets | -138.1% |
| Return on Invested Capital | -199.1% |
| Gross Profit Margin (Quarterly) | 33.33% |
| Operating Margin (Quarterly) | -3.19K% |
| Return on Net Operating Assets | -736.0% |